Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 14/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | TMIGD3 | P0DMS9 | 2/20 | 0.65 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | XBP1 | P17861 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7685244 | 0.93 | ADORA3 (0.67) | ADORA3KDM4ELMNATMIGD3TRPV1 | |
| SCHEMBL7689604 | 0.86 | ADORA3 (0.65) | ADORA3KDM4ELMNATMIGD3TRPV1 | |
| SCHEMBL7680777 | 0.86 | ADORA3 (1.00) | ADORA3TMIGD3TRPV1ALDH1A1CACNA1D | |
| SCHEMBL1664685 | 0.85 | ADORA3 (0.71) | ADORA3KDM4ELMNATMIGD3TRPV1 | |
| SCHEMBL7685108 | 0.83 | ADORA3 (0.74) | ADORA3KDM4ETMIGD3TRPV1ALDH1A1 | |
| SCHEMBL7687307 | 0.81 | ADORA3 (1.00) | ADORA3TMIGD3TRPV1ALDH1A1CACNA1D | |
| SCHEMBL3503405 | 0.81 | KDM4E (1.00) | KDM4ELMNAALDH1A1CACNA1DMEN1 | |
| SCHEMBL7386505 | 0.79 | ADORA3 (0.56) | ADORA3KDM4ELMNATMIGD3TRPV1 | |
| SCHEMBL13932305 | 0.79 | ADORA3 (1.00) | ADORA3KDM4ELMNATMIGD3TRPV1 | |
| SCHEMBL7383408 | 0.79 | ALDH1A1 (0.57) | ADORA3KDM4ETMIGD3TRPV1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6376521-B1 | ANTIINFLAMMATORY AGENTS; ANTIISCHEMIC AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2002-04-23 | — | — | US | claimed |
| US-6376521-B1 | ANTIINFLAMMATORY AGENTS; ANTIISCHEMIC AGENTS; CENTRAL NERVOUS SYSTEM DISORDERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2002-04-23 | — | — | US | disclosed |